Mannatech's shareholders approved all proposals at the annual meeting, including board elections and auditor ratification.
Quiver AI Summary
Mannatech, Incorporated, a global health and wellness company, announced that its shareholders approved all proposals during its annual meeting on June 2, 2026. The meeting, chaired by Chairman J. Stanley Fredrick, included a financial report for 2025 presented by Interim CFO Yasir Haider. A total of 1,369,880 shares were represented at the meeting, accounting for 71% of shares entitled to vote. Shareholders elected two Directors, ratified the appointment of BDO USA, P.C. as the independent accounting firm for the fiscal year ending December 31, 2026, and approved the advisory compensation for named executives. Mannatech has over 25 years of experience in offering high-quality nutritional and wellness products through a network of independent associates.
Potential Positives
- Shareholders passed all proposals at the annual meeting, reflecting strong support for the company's governance and strategic direction.
- The election of new Board members indicates continued investment in leadership, which can positively influence business strategy and growth.
- The approval of the independent accounting firm's appointment suggests confidence in financial oversight and transparency, which can enhance investor trust.
- Shareholders approved the compensation of executive officers, highlighting alignment between management and shareholder interests, which can support organizational stability and performance.
Potential Negatives
- Low voter turnout with only 71.0% of shares voted, potentially indicating shareholder apathy or disinterest in corporate governance.
- Significant number of votes withheld for Board nominees, suggesting concerns among shareholders regarding leadership quality or direction.
- Approval of executive compensation faced notable opposition, with a substantial percentage of shareholders voting against it, which may reflect dissatisfaction with management performance.
FAQ
What were the main outcomes of Mannatech's 2026 annual shareholder meeting?
Mannatech's shareholders passed all proposals, including the election of two new Board Directors and the ratification of BDO USA as their accounting firm.
How many shares were voted at the Mannatech meeting?
A total of 1,369,880 shares were voted, representing 71.0% of the outstanding shares entitled to vote.
Who reported the financial results at the annual meeting?
Yasir Haider, the Interim Chief Financial Officer, reported the financial results for the year 2025.
When was the record date for voting at the Mannatech meeting?
The record date for determining voting shareholders was April 6, 2026.
What is the focus of Mannatech's business?
Mannatech focuses on developing and marketing high-quality nutritional supplements and wellness products through a global network of associates.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MTEX Insider Trading Activity
$MTEX insiders have traded $MTEX stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MTEX stock by insiders over the last 6 months:
- LARRY A JOBE has made 2 purchases buying 7,803 shares for an estimated $32,548 and 0 sales.
- KEVIN ANDREW ROBBINS purchased 7,100 shares for an estimated $29,607
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MTEX Revenue
$MTEX had revenues of $26.6M in Q4 2025. This is a decrease of -8.18% from the same period in the prior year.
You can track MTEX financials on Quiver Quantitative's MTEX stock page.
You can access data on MTEX stock through the Quiver Quantitative API.
$MTEX Hedge Fund Activity
We have seen 5 institutional investors add shares of $MTEX stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC removed 11,579 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $66,926
- RENAISSANCE TECHNOLOGIES LLC removed 900 shares (-2.8%) from their portfolio in Q1 2026, for an estimated $5,202
- DIMENSIONAL FUND ADVISORS LP removed 753 shares (-5.9%) from their portfolio in Q1 2026, for an estimated $4,352
- TOWER RESEARCH CAPITAL LLC (TRC) removed 685 shares (-59.2%) from their portfolio in Q1 2026, for an estimated $3,959
- MAI CAPITAL MANAGEMENT removed 684 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,643
- FARTHER FINANCE ADVISORS, LLC removed 332 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,739
- VANGUARD GROUP INC removed 186 shares (-0.4%) from their portfolio in Q4 2025, for an estimated $1,534
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
FLOWER MOUND, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (Nasdaq: MTEX ) (the "Company"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders passed all proposals put to a vote at the Company’s annual shareholder meeting (the "Meeting") held Tuesday, June 2, 2026.
Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and Yasir Haider, Interim Chief Financial Officer, reported to the shareholders on the Company’s 2025 financial results.
At the close of business on April 6, 2026, the record date for determining shareholders entitled to vote at the Meeting, there were 1,929,670 shares of the Company’s common stock, par value $0.0001 per share, outstanding (the “Shares”). Proxies representing 1,369,880 Shares were received, validated, and voted at the Meeting, constituting 71.0% of the Shares entitle to vote.
The following matters were submitted and voted upon at the Meeting.
1. Mannatech shareholders voted on the election of two individuals to the Board of Directors as Class III Directors to hold office until 2029 as set forth below:
| Name |
Number of Shares
For |
Number of Shares
Withheld |
Broker
Non-Votes |
| John A. Seifrick | 879,504 | 213,248 | 277,128 |
| Robert Toth | 937,930 | 154,822 | 277,128 |
2. Mannatech shareholders voted to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ended December 31, 2026, as set forth below:
|
Number of Shares
For |
Number of Shares
Against |
Number of Shares
Abstaining |
Broker
Non-Votes |
| 1,205,072 | 164,415 | 393 | 0 |
3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech’s named executive officers as set forth below:
|
Number of Shares
For |
Number of Shares
Against |
Number of Shares
Abstaining |
Broker
Non-Votes |
| 947,313 | 143,740 | 1,699 | 277,128 |
About Mannatech
Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit Mannatech.com.
^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.
Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Investor Relations Contact Information:
Erin K. Barta
General Counsel and Corporate Secretary
972-471-7742
[email protected]
www.mannatech.com